Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1

205.477.001039 Boehringer Ingelheim Investigational Site, Birmingham

205.477.001050 Boehringer Ingelheim Investigational Site, Birmingham

205.477.001021 Boehringer Ingelheim Investigational Site, Florence

205.477.001046 Boehringer Ingelheim Investigational Site, Fountain Valley

205.477.001052 Boehringer Ingelheim Investigational Site, Sacramento

205.477.001059 Boehringer Ingelheim Investigational Site, San Diego

205.477.001009 Boehringer Ingelheim Investigational Site, Stamford

205.477.001040 Boehringer Ingelheim Investigational Site, Waterbury

205.477.001051 Boehringer Ingelheim Investigational Site, Brandon

205.477.001044 Boehringer Ingelheim Investigational Site, Clearwater

205.477.001037 Boehringer Ingelheim Investigational Site, Eustis

205.477.001017 Boehringer Ingelheim Investigational Site, Miami

205.477.001063 Boehringer Ingelheim Investigational Site, Miami

205.477.001001 Boehringer Ingelheim Investigational Site, St. Petersburg

205.477.001004 Boehringer Ingelheim Investigational Site, Decatur

205.477.001012 Boehringer Ingelheim Investigational Site, Duluth

205.477.001064 Boehringer Ingelheim Investigational Site, Belleville

205.477.001038 Boehringer Ingelheim Investigational Site, Muncie

205.477.001007 Boehringer Ingelheim Investigational Site, Baltimore

205.477.001014 Boehringer Ingelheim Investigational Site, Columbia

205.477.001018 Boehringer Ingelheim Investigational Site, Livonia

205.477.001068 Boehringer Ingelheim Investigational Site, Union

205.477.001035 Boehringer Ingelheim Investigational Site, Cooperstown

205.477.001023 Boehringer Ingelheim Investigational Site, New York

205.477.001061 Boehringer Ingelheim Investigational Site, Staten Island

205.477.001027 Boehringer Ingelheim Investigational Site, Burlington

205.477.001032 Boehringer Ingelheim Investigational Site, Huntersville

205.477.001020 Boehringer Ingelheim Investigational Site, Seneca

205.477.001034 Boehringer Ingelheim Investigational Site, Cincinnati

205.477.001053 Boehringer Ingelheim Investigational Site, Columbus

205.477.001011 Boehringer Ingelheim Investigational Site, Dayton

205.477.001057 Boehringer Ingelheim Investigational Site, Tulsa

205.477.001006 Boehringer Ingelheim Investigational Site, Portland

205.477.001083 Boehringer Ingelheim Investigational Site, Downingtown

205.477.001031 Boehringer Ingelheim Investigational Site, Monroeville

205.477.001028 Boehringer Ingelheim Investigational Site, Anderson

205.477.001019 Boehringer Ingelheim Investigational Site, Charleston

205.477.001010 Boehringer Ingelheim Investigational Site, Fort Mill

205.477.001025 Boehringer Ingelheim Investigational Site, Gaffney

205.477.001002 Boehringer Ingelheim Investigational Site, Rock Hill

205.477.001026 Boehringer Ingelheim Investigational Site, Spartanburg

205.477.001015 Boehringer Ingelheim Investigational Site, Union

205.477.001013 Boehringer Ingelheim Investigational Site, Nashville

205.477.001022 Boehringer Ingelheim Investigational Site, Corsicana

205.477.001055 Boehringer Ingelheim Investigational Site, Fort Worth

205.477.001054 Boehringer Ingelheim Investigational Site, Katy

205.477.001062 Boehringer Ingelheim Investigational Site, Tyler

205.477.001030 Boehringer Ingelheim Investigational Site, Abingdon

205.477.001008 Boehringer Ingelheim Investigational Site, Roanoke

205.477.001043 Boehringer Ingelheim Investigational Site, San Juan